ILMN Jan 2026 100.000 call
| Previous close | 41.70 |
| Open | 50.70 |
| Bid | 48.50 |
| Ask | 49.90 |
| Strike | 100.00 |
| Expiry date | 2026-01-16 |
| Day's range | 50.70 - 50.70 |
| Contract range | N/A |
| Volume | |
| Open interest | 4 |
ZacksGSK Meets Study Goal for Co-Administered RSV-Shingles Vaccines
Data from a late-stage study shows that co-administering GSK's RSV and Shingles vaccines together was as effective as giving each separately.
PR NewswireIllumina and LGC Biosearch Technologies join forces to drive genomic innovation in agriculture
Illumina (NASDAQ: ILMN) a global leader in genomics, and LGC Biosearch Technologies™, a pioneer in agricultural genomics, today announced a strategic partnership to accelerate the adoption of genomics in agricultural applications. By combining Biosearch Technologies' targeted genotyping-by-sequencing library preparation methodology (Amp-Seq) with Illumina's proven and highly scalable sequencing technology, the partnership aims to deliver innovative solutions to researchers and breeders in the As
- Zacks
Ascendis Soars on Encouraging Data From Dwarfism Drug Study
ASND stock surges after data from a study shows that its investigational achondroplasia therapy achieved the primary study goal.
